RanjuGuptaMD

Lehigh Valley Health Network

Overview of Dr. Gupta

Dr. Ranju Gupta is an oncologist in Allentown, PA and is affiliated with multiple hospitals in the area, including Lehigh Valley Hospital-Cedar Crest, Lehigh Valley Health Network - Muhlenberg, and Good Shepherd Specialty Hospital. She received her medical degree from Lady Hardinge Medical College and has been in practice 21 years. Dr. Gupta accepts several types of health insurance, listed below. She is one of 18 doctors at Lehigh Valley Health Network - Muhlenberg and one of 44 doctors at Lehigh Valley Hospital-Cedar Crest who specialize in Oncology. She has more than 10 publications and over 100 citings.

Office
1240 S Cedar Crest Blvd
Suite 401
Allentown, PA 18103
Book by Phone+1(484) 867-8183

Education & Training

NYC Health & Hospitals/South Brooklyn HealthResidency, Internal Medicine, 2003 - 2005
Lady Hardinge Medical CollegeClass of 1996

Certifications & Licensure

PA State Medical License 2008 - 2024
NY State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Completed
Phase 3

Publications & Presentations

PubMed

3 citations
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process.
Erin F Gillespie, Noah J Mathis, Max Vaynrub, Ernesto Santos Martin, Rupesh Kotecha
Clinical and Translational Radiation Oncology. 2022-07-01
22 citations
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithAmplification orMutations: Results From the TAPUR Study.
Ranju Gupta, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat
JCO Precision Oncology. 2022-10-01
2 citations
Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy.
Mallorie L Huff, Joshua A Kalter, Ramona E Chase, Ranju Gupta
Cureus. 2022-01-01

Lectures

Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida BlueSelect
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
Capital BC Keystone Health Plan Central HMO
Capital Blue Cross PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment